BIODESIX INC - Common Stock, par value $0.001 per share (BDSX)

CUSIP: 09075X207

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
9,724,771
Total 13F shares
1,342,428
Share change
+193,248
Total reported value
$9,128,098
Price per share
$6.80
Number of holders
25
Value change
+$1,239,023
Number of buys
13
Number of sells
12

Security key

09075X207

Report period

Q4 2025

Institutions

25

Top holders

10

Top shareholders of BDSX - BIODESIX INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Jack W. Schuler
13D/G
SCHULER JACK W
26%
39,821,357
$16,326,756 +$1,430,233 29 Aug 2025
Telemark Asset Management, LLC
13F
Company
4.3%
414,124
$3,126,636 30 Sep 2025
13F
Birchview Capital, LP
13F
Company
2.7%
286,804
$2,165,370 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
1.9%
181,904
$1,373,376 30 Sep 2025
13F
PERCEPTIVE ADVISORS LLC
13F
Company
1.1%
108,694
$820,639 30 Sep 2025
13F
Monashee Investment Management LLC
13F
Company
1%
99,996
$754,970 30 Sep 2025
13F
PERKINS CAPITAL MANAGEMENT INC
13F
Company
0.54%
52,633
$397,379 30 Sep 2025
13F
Charles M. Watts
3/4/5
Director
mixed-class rows
458,755
mixed-class rows
$389,740 31 Mar 2025
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.51%
49,607
$374,533 30 Sep 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.5%
48,342
$365,000 30 Sep 2025
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.44%
43,024
$324,831 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.41%
40,218
$303,731 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
0.25%
24,466
$184,718 30 Sep 2025
13F
STATE STREET CORP
13F
Company
0.16%
15,402
$116,285 30 Sep 2025
13F
ORACLE INVESTMENT MANAGEMENT INC
13F
Company
0.15%
15,000
$113,250 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.15%
14,944
$112,827 30 Sep 2025
13F
Shay Capital LLC
13F
Company
0.14%
14,005
$105,738 30 Sep 2025
13F
Cannell & Spears LLC
13F
Company
0.11%
10,279
$77,606 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.09%
8,901
$67,000 30 Sep 2025
13F
Ryan H. Siurek
3/4/5
Chief Accounting Officer
mixed-class rows
43,825
mixed-class rows
$53,711 08 May 2023
Robert William Georgantas III
3/4/5
Chief Scientific Officer
class O/S missing
38,214
$46,836 21 Nov 2022
Allworth Financial LP
13F
Company
0.05%
4,965
$37,486 30 Sep 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.02%
1,466
$11,068 30 Sep 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
644
$4,862 30 Sep 2025
13F
Fortitude Family Office, LLC
13F
Company
0%
171
$1,291 30 Sep 2025
13F
GROUP ONE TRADING LLC
13F
Company
0%
100
$755 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0%
76
$574 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
30
$226 30 Sep 2025
13F
BARCLAYS PLC
13F
Company
0%
1
$8 30 Sep 2025
13F
FMR LLC
13F
Company
0%
1
$8 30 Sep 2025
13F

Institutional Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q4 2025

As of 31 Dec 2025, BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,342,428 shares. The largest 10 holders included Telemark Asset Management, LLC, Aberdeen Group plc, VANGUARD GROUP INC, Monashee Investment Management LLC, PERCEPTIVE ADVISORS LLC, GSA CAPITAL PARTNERS LLP, PERKINS CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Balyasny Asset Management L.P., and Trexquant Investment LP. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
25
Q4 2025 holders
25
Holder diff
0
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .